| Meropenem pharmacokinetics changes during the septic shock with impact on coverage based on PK/PD approach in critically burn patients | |
| Nursing diagnosis of fatigue in pleople with venous ulcer: cross-sectional study | |
| Pain and self-medication in people with venous ulcer | |
| Body image disorder: defining characteristics and related factors in pleople with venous ulcers | |
| Self-esteem and quality of life in people with venous ulcer | |
| Anxiety in people with venous ulcer | |
| Impaired comfort in people with venous ulcer | |
| Self-esteem and self-efficacy in people with venous ulcers | |
| Self-efficacy and quality of life in people with venous ulcer | |
| Adhesion to treatment and quality of life in people with venous ulcer | |
| Correlation between self-efficacy and quality of life assessed by the Charing Cross Venous Ulcer Questionnaire in people with venous ulcers | |
| Direct costs of pressure injury dressing in patients under intensive care | |
| Academic League in Stomal Therapy: challenges and overcoming in times of Pandemic |
| Pharmacokinetics-pharmacodynamics approach for comparison of Piperacillin/Tazobactam effectiveness, two dose regimens in septic burn patients | |
| Photodynamic therapy associated with special coverages in pressure injury in a university hospital: A relevant case study | |
| The silent threat - alkali foot burn, a case report | |
| Negative pressure therapy treatment in Abdominal retail necrosis after abdominal Dermolipectomy | |
| Use of low-level light and photodynamics therapies in the treatment of pioderma gangrenous injury |
| Ozone therapy transcutaneous versus Fotobiomodulation in treating burn | |
| Ozone therapy in the therapeutic approach to the management of leukocytoclastic vasculitis | |
| High Definition Submental Liposuction |
| Vancomycin dose adjustment in critically ill burn patients by pharmacokinetic-pharmacodynamic approach against Gram-positive MIC 2 mg/L strains | |
| Pharmacokinetic changes can impact vancomycin target attainment in critically ill oncologic patients | |
| Association of hyperbaric oxygen therapy and laser therapy in the healing of Achilles tendon rupture | |
| Educational Technology for the prevention of Friction Injuries in the elderly: Animated Infographic | |
| Vancomycin dose adjustment based on pharmacokinetic-pharmacodynamic approach is required in critically ill oncological patients against isolated strains MIC 1-2 mg/L |
| Association between antimicrobial photodynamic therapy and photobiomodulation in the healing process of skin wounds in dog (Canis lupus familiaris) | |
| Photobiomodulation in post covid pressure injury: A series of case reports | |
| Management of surgical wound dehiscence in a specialized wound care center: A case series | |
| Role of nurses in the treatment of injury due to drug extravasation with vesicanting property | |
| Effectiveness improvement through Meropenem 1g q8h by 3hrs-extended infusion in critically ill burn patients at the earlier period of septic shock against intermediate susceptibility (4-8mg/L) of P. aeruginosa | |
| Pharmacokinetics-pharmacodynamics approach for Meropenem and Piperacillin/Tazobactam after extended infusion improves effectiveness in septic burn patients with renal function preserved |
| Clinical parameters for assessment skin oiliness in surgical patients | |
| Heels skin oiliness: symmetry between body sides | |
| Heels skin oiliness of patients in the operating room with risk of developing pressure injuries | |
| Piperacillin-vancomycin effectiveness by PK/PD approach in septic burn patients receiving the empiric dose regimen recommended for renal failure | |
| Vancomycin target attainment against Gram-positive MIC 2 mg/L strains in critically ill burn patients | |
| Meropenem extended infusion in burn patients for drug effectiveness at the earlier period of septic shock against Gram-negative nosocomial MIC 4 mg/L strains | |
| Piperacillin/Tazobactam effectiveness by comparison of dose regimens recommended for septic burn patients requiring vasopressors by applying pharmacokinetics-pharmacodynamics approach | |
| Advanced wound healing with application of products with diversified propolis |
Imprimire Comunicação
Fone: +55 (11) 98528-0458 / 96795-7601
Email: contato@sobratafe.com.br
